Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Buse

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Survey of Immunologic Research|January 1, 1982
Disordered cellular immunity in type I diabetes of man and the BB ratJ B Buse, R F Rowley, G S Eisenbarth
Diabetes, Obesity & Metabolism|January 30, 2004
The effects of oral anti-hyperglycaemic medications on serum lipid profiles in patients with type 2 diabetesJ B Buse, M H Tan, M J Prince, et al.
Transplantation|January 1, 1993
Inhibition of glucose-stimulated insulin release from beta TC3 cells and rodent islets by an analog of FK506K C Herold, S Nagamatsu, J B Buse, et al.
The Journal of Clinical Investigation|October 1, 1991
Analysis of the gene sequences of the insulin receptor and the insulin-sensitive glucose transporter (GLUT-4) in patients with common-type non-insulin-dependent diabetes mellitusJ Kusari, U S Verma, J B Buse, et al.
International Journal of Obesity (2005)|May 5, 2016
Novel measures of inflammation and insulin resistance are related to obesity and fitness in a diverse sample of 11-14 year olds: The HEALTHY StudyR Jago, K L Drews, J D Otvos, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 11, 2011
Patient-reported outcomes are superior in patients with Type 2 diabetes treated with liraglutide as compared with exenatide, when added to metformin, sulphonylurea or both: results from a randomized, open-label studyW E Schmidt, J S Christiansen, M Hammer, et al.
Diabetes, Obesity & Metabolism|August 12, 2014
Dipeptidyl-peptidase-4 inhibitors and pancreatic cancer: a cohort studyM Gokhale, J B Buse, C L Gray, et al.
Diabetes, Obesity & Metabolism|May 21, 2014
Subcutaneous injection of hyaluronidase with recombinant human insulin compared with insulin lispro in type 1 diabetesS K Garg, J B Buse, J S Skyler, et al.
The Journal of Biological Chemistry|May 15, 1989
Cloning and characterization of the major insulin-responsive glucose transporter expressed in human skeletal muscle and other insulin-responsive tissuesH Fukumoto, T Kayano, J B Buse, et al.
Diabetes Care|September 4, 1998
Troglitazone use in insulin-treated type 2 diabetic patients. The Troglitazone Insulin Study GroupJ B Buse, B Gumbiner, N P Mathias, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Survey of Immunologic Research|January 1, 1982
Disordered cellular immunity in type I diabetes of man and the BB ratJ B Buse, R F Rowley, G S Eisenbarth
Diabetes, Obesity & Metabolism|January 30, 2004
The effects of oral anti-hyperglycaemic medications on serum lipid profiles in patients with type 2 diabetesJ B Buse, M H Tan, M J Prince, et al.
Transplantation|January 1, 1993
Inhibition of glucose-stimulated insulin release from beta TC3 cells and rodent islets by an analog of FK506K C Herold, S Nagamatsu, J B Buse, et al.
The Journal of Clinical Investigation|October 1, 1991
Analysis of the gene sequences of the insulin receptor and the insulin-sensitive glucose transporter (GLUT-4) in patients with common-type non-insulin-dependent diabetes mellitusJ Kusari, U S Verma, J B Buse, et al.
International Journal of Obesity (2005)|May 5, 2016
Novel measures of inflammation and insulin resistance are related to obesity and fitness in a diverse sample of 11-14 year olds: The HEALTHY StudyR Jago, K L Drews, J D Otvos, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 11, 2011
Patient-reported outcomes are superior in patients with Type 2 diabetes treated with liraglutide as compared with exenatide, when added to metformin, sulphonylurea or both: results from a randomized, open-label studyW E Schmidt, J S Christiansen, M Hammer, et al.
Diabetes, Obesity & Metabolism|August 12, 2014
Dipeptidyl-peptidase-4 inhibitors and pancreatic cancer: a cohort studyM Gokhale, J B Buse, C L Gray, et al.
Diabetes, Obesity & Metabolism|May 21, 2014
Subcutaneous injection of hyaluronidase with recombinant human insulin compared with insulin lispro in type 1 diabetesS K Garg, J B Buse, J S Skyler, et al.
The Journal of Biological Chemistry|May 15, 1989
Cloning and characterization of the major insulin-responsive glucose transporter expressed in human skeletal muscle and other insulin-responsive tissuesH Fukumoto, T Kayano, J B Buse, et al.
Diabetes Care|September 4, 1998
Troglitazone use in insulin-treated type 2 diabetic patients. The Troglitazone Insulin Study GroupJ B Buse, B Gumbiner, N P Mathias, et al.
Pageof 5